Exploring the Association Between Emphysema Phenotypes and Low Bone Mineral Density in Smokers with and without COPD

References

• LawMR, HackshawAK, DaniellH, et al. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ. 1997;315(7112):841–846. doi:10.1136/bmj.315.7112.8419353503
   PubMed Web of Science ®Google Scholar
• PompeE, BartstraJ, VerhaarHJ, et al. Bone density loss on computed tomography at 3-year follow-up in current compared to former male smokers. Eur J Radiol. 2017;89:177–181. doi:10.1016/j.ejrad.2017.02.01128267536
   PubMed Web of Science ®Google Scholar
• SinDD, ManJP, ManSFP. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med. 2003;114(1):10–14. doi:10.1016/S0002-9343(02)01297-412543283
   PubMed Web of Science ®Google Scholar
• de VriesF, van StaaTP, BrackeMSGM, CooperC, LeufkensHGM, LammersJ-WJ. Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J. 2005;25(5):879–884. doi:10.1183/09031936.05.0005820415863646
   PubMed Web of Science ®Google Scholar
• BoltonCE, IonescuAA, ShielsKM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(12):1286–1293. doi:10.1164/rccm.200406-754OC15374843
   PubMed Web of Science ®Google Scholar
• OharaT, HiraiT, MuroS, et al. Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD. Chest. 2008;134(6):1244–1249. doi:10.1378/chest.07-305418641115
   PubMed Web of Science ®Google Scholar
• BonJ, FuhrmanCR, WeissfeldJL, et al. Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med. 2011;183(7):885–890.20935108
   PubMed Web of Science ®Google Scholar
• ChurgA, DaiJ, TaiH, XieC, WrightJL. Tumor necrosis factor-α is central to acute cigarette smoke–induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med. 2002;166(6):849–854. doi:10.1164/rccm.200202-097OC12231496
   PubMed Web of Science ®Google Scholar
• ChurgA, WangRD, TaiH, WangX, XieC, WrightJL. Tumor necrosis factor-α drives 70% of cigarette smoke–induced emphysema in the mouse. Am J Respir Crit Care Med. 2004;170(5):492–498. doi:10.1164/rccm.200404-511OC15184206
   PubMed Web of Science ®Google Scholar
• PompeE, de JongPA, van RikxoortEM, et al. Smokers with emphysema and small airway disease on computed tomography have lower bone density. Int J Chron Obstruct Pulmon Dis. 2016;11:1207–1216. doi:10.2147/COPD.S10368027354779
   PubMed Web of Science ®Google Scholar
• BonJ, ZhangY, LeaderJK, et al. Radiographic emphysema, circulating bone biomarkers, and progressive bone mineral density loss in smokers. Ann Am Thorac Soc. 2018;15:615–621. doi:10.1513/AnnalsATS.201709-743OC29328885
   PubMed Web of Science ®Google Scholar
• SmithBM, AustinJHM, NewellJD, et al. Pulmonary emphysema subtypes on computed tomography: the MESA COPD study. Am J Med. 2014;127(1):94.e7–94.e23. doi:10.1016/j.amjmed.2013.09.020
   Web of Science ®Google Scholar
• CopleySJ, WellsAU, MüllerNL, et al. Thin-section CT in obstructive pulmonary disease: discriminatory value. Radiology. 2002;223(3):812–819. doi:10.1148/radiol.223301076012034954
   PubMed Web of Science ®Google Scholar
• KukkonenMK, TiiliE, VehmasT, OksaP, PiiriläP, HirvonenA. Association of genes of protease-antiprotease balance pathway to lung function and emphysema subtypes. BMC Pulm Med. 2013;13:1. doi:10.1186/1471-2466-13-3623305075
   PubMed Web of Science ®Google Scholar
• EngsigMT, ChenQJ, VuTH, et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol. 2000;151(4):879–889. doi:10.1083/jcb.151.4.87911076971
   PubMed Web of Science ®Google Scholar
• BoltonCE, StoneMD, EdwardsPH, DuckersJM, EvansWD, ShaleDJ. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2009;6(2):81–87. doi:10.1177/147997230910313119411568
   PubMedGoogle Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med 2017;195(5):557–82.
   Google Scholar
• WedzichaJA, SeemungalTA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370:786–796. doi:10.1016/S0140-6736(07)61382-817765528
   PubMed Web of Science ®Google Scholar
• CelliBR, MacneeW. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946.15219010
   PubMed Web of Science ®Google Scholar
• RocaJ, BurgosF, SunyerJ, et al. References values for forced spirometry. Group of the European Community Respiratory Health Survey. Eur Respir J. 1998;11(6):1354–1362. doi:10.1183/09031936.98.110613549657579
   PubMed Web of Science ®Google Scholar
• CrapoRO, CasaburiR, CoatesAL, et al. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117.12091180
   PubMed Web of Science ®Google Scholar
• Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994;4(6):368–381. doi:10.1007/BF1622200
   Google Scholar
• HenschkeCI, MccauleyDI, YankelevitzDF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet. 1999;354:99–105.10408484
   PubMed Web of Science ®Google Scholar
• SocietyF, AustinJHM, HoggJC, et al. Chronic obstructive pulmonary disease: a statement of the Fleischner Society. Radiology. 2015;277(1):192–205.25961632
   PubMed Web of Science ®Google Scholar
• National Emphysema Treatment Trial Research Group, Fishman A, Fessler H, et al. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001;345(15):1075–1083. doi:10.1056/NEJMoa11798
   Google Scholar
• CetinA, Gökçe-KutsalY, CelikerR. Predictors of bone mineral density in healthy males. Rheumatol Int. 2001;21(3):85–88. doi:10.1007/s00296-001-0142-211765226
   PubMed Web of Science ®Google Scholar
• BarreraG, BunoutD, GattásV, De La MazaMP, LeivaL, HirschS. A high body mass index protects against femoral neck osteoporosis in healthy elderly subjects. Nutrition. 2004;20(9):769–771. doi:10.1016/j.nut.2004.05.01415325685
   PubMed Web of Science ®Google Scholar
• KirchengastS, PetersonB, HauserG, KnoglerW. Body composition characteristics are associated with the bone density of the proximal femur end in middle- and old-aged women and men. Maturitas. 2001;39(2):133–145. doi:10.1016/S0378-5122(01)00205-511514112
   PubMed Web of Science ®Google Scholar
• KirchengastS, KnoglerW, HauserG. Protective effect of moderate overweight on bone density of the hip joint in elderly and old Austrians. Anthropol Anz. 2002;60(2):187–197. doi:10.1127/anthranz/60/2002/18712161964
   PubMedGoogle Scholar
• WeeJ, SngBYJ, ShenL, LimCT, SinghG, Das DeS. The relationship between body mass index and physical activity levels in relation to bone mineral density in premenopausal and postmenopausal women. Arch Osteoporos. 2013;8(1–2). doi:10.1007/s11657-013-0162-z
   PubMed Web of Science ®Google Scholar
• EspallarguesM, Sampietro-ColomL, EstradaMD, et al. Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int. 2001;12(10):811–822. doi:10.1007/s00198017003111716183
   PubMed Web of Science ®Google Scholar
• MazessRB, BardenHS. Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pills. Am J Clin Nutr. 1991;53(1):132–142. doi:10.1093/ajcn/53.1.1321984338
   PubMed Web of Science ®Google Scholar
• Van der VoortDJM, GeusensPP, DinantGJ. Risk factors for osteoporosis related to their outcome: fractures. Osteoporos Int. 2001;12(8):630–638. doi:10.1007/s00198017006211580076
   PubMed Web of Science ®Google Scholar
• CummingsSR, NevittMC, BrownerWS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332(12):767–773. doi:10.1056/NEJM1995032333212027862179
   PubMed Web of Science ®Google Scholar
• EnsrudKE, EwingSK, StoneKL, CauleyJA, BowmanPJ, CummingsSR. Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women. J Am Geriatr Soc. 2003;51(12):1740–1747. doi:10.1046/j.1532-5415.2003.51558.x14687352
   PubMed Web of Science ®Google Scholar
• RuttenEPA, GrydelandTB, PillaiSG, et al. Quantitative CT: associations between emphysema, airway wall thickness and body composition in COPD. Pulm Med. 2011;2011:1–6. doi:10.1155/2011/419328
   Google Scholar
• MakitaH, NasuharaY, NagaiK, et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax. 2007;62(11):932–937. doi:10.1136/thx.2006.07277717573447
   PubMed Web of Science ®Google Scholar
• CelliBR, LocantoreN, Tal-SingerR, et al. Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype. Eur Respir J. 2018;51(2):1702146. doi:10.1183/13993003.02146-201729437944
   PubMed Web of Science ®Google Scholar
• SambrookP, CooperC. Osteoporosis. Lancet. 2006;367(9527):2010–2018. doi:10.1016/S0140-6736(06)68891-016782492
   PubMed Web of Science ®Google Scholar
• RaiszLG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005;115:3318–3325. doi:10.1172/JCI2707116322775
   PubMed Web of Science ®Google Scholar
• CouillinI, VasseurV, CharronS, et al. IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema. J Immunol. 2009;183(12):8195–8202. doi:10.4049/jimmunol.080315420007584
   PubMed Web of Science ®Google Scholar
• ChurgA, ZhouS, WangX, WangR, WrightJL. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol. 2009;40(4):482–490. doi:10.1165/rcmb.2008-0038OC18931327
   PubMed Web of Science ®Google Scholar
• XiongZ, LemeAS, RayP, ShapiroSD, LeeJS. CX3CR1+ lung mononuclear phagocytes spatially confined to the interstitium produce TNF- and IL-6 and promote cigarette smoke-induced emphysema. J Immunol. 2011;186(5):3206–3214. doi:10.4049/jimmunol.100322121278339
   PubMed Web of Science ®Google Scholar
• RuwanpuraSM, McLeodL, MillerA, et al. Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice. Am J Respir Cell Mol Biol. 2011;45(4):720–730. doi:10.1165/rcmb.2010-0462OC21297079
   PubMed Web of Science ®Google Scholar
• ChenK, PociaskDA, McAleerJP, et al. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One. 2011;6(5:)e20333.21647421
   PubMed Web of Science ®Google Scholar
• BonJM, ZhangY, DuncanSR, et al. Plasma inflammatory mediators associated with bone metabolism in COPD. Copd. 2010;7:186–191. doi:10.3109/15412555.2010.48211420486817
   PubMedGoogle Scholar
• ItoI, NagaiS, HandaT, et al. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med. 2005;172(11):1378–1382. doi:10.1164/rccm.200506-953OC16126934
   PubMed Web of Science ®Google Scholar